Related Experiment Video
Updated: Mar 22, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
14.0K
[Recent Therapy of Organ-confined Testis Cancer]
C Breunig1, F Zengerling1, T Schnöller1
1Klinik für Urologie und Kinderurologie, Universitätsklinikum Ulm.
Aktuelle Urologie
|April 15, 2016
Summary
Testicular cancer is rare but common in young men. Advances in chemotherapy offer excellent prognoses, prompting research into less radical treatments and surveillance for localized cases.
Area of Science:
- Oncology
- Urology
Background:
- Testicular cancer represents 1-2% of all malignant tumors in Germany.
- It is the most prevalent cancer among men aged 20-35, impacting life and family planning.
- Excellent prognoses are achievable with platinum-based chemotherapy, though long-term side effects exist.
Purpose of the Study:
- To provide an overview of the current therapeutic standards for stage I testicular cancer.
- To discuss risk-adapted treatment strategies and surveillance for localized testicular cancer.
- To explore implications for organ-sparing surgery in testicular cancer management.
Main Methods:
- Selective literature review using PubMed.
- Analysis of current therapeutic standards for stage I testicular cancer.
- Evaluation of risk-adapted approaches and surveillance strategies.
Main Results:
- Organ-sparing surgery may have implications for localized testicular cancer.
- A risk-adapted therapeutic approach offers benefits for patients.
- Surveillance strategies are indicated for specific patient groups with localized testicular cancer.
Conclusions:
- Current therapeutic strategies for stage I testicular cancer prioritize reducing treatment radicality.
- Risk stratification and surveillance are key components of modern testicular cancer management.
- Minimizing long-term toxicity while maintaining excellent outcomes is the focus of ongoing research.
Related Concept Videos
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:56Treatment Resistent Cancers
1.5K
1.5K
01:20Disorders of the Male Reproductive System
5.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:27Testes: Histology
3.5K
A tough, fibrous membrane, the tunica albuginea, covers the testes, extending inward to form fibrous partitions or septa, dividing them into internal compartments called lobules. Each lobule has 1 to 3 tightly coiled seminiferous tubules where sperm production occurs. These tubules merge into a tubular network at the back of the testis, known as the rete testis. It connects to 15 to 20 efferent ductules, leading to the epididymis.
The spermatogenic cells, responsible for producing sperm, are...
The spermatogenic cells, responsible for producing sperm, are...
3.5K